摘要
氧化/硝化损伤是导致肺癌发生的重要因素之一。一氧化氮(NO)自由基通过酪氨酸硝化等化学修饰参与肺癌的发生和转移。NO介导的蛋白质硝化是肺癌中一种重要的分子事件,它是在酪氨酸残基的酚环第3位上添加硝基(-NO2)基团的产物。硝化参与多种生物学过程,包括信号转导、蛋白质降解、能量代谢、线粒体功能障碍、酶失活、免疫原反应、凋亡和细胞死亡。本文综述了NO及其衍生物与肺癌的关系、酪氨酸硝化在肺癌中的形成和作用、肺癌与其他炎症性肺部疾病蛋白硝化的差异、蛋白质硝化和硝基蛋白组学在肺癌中的研究现状,以及更好地理解肺癌发生、生物标志物发现、新的诊断、预后监测和治疗靶点的前景。
关键词: 肺癌,酪氨酸硝化,硝基蛋白质组学,质谱,系统生物学,结构生物学。
Current Medicinal Chemistry
Title:Protein Tyrosine Nitration in Lung Cancer: Current Research Status and Future Perspectives
Volume: 25 Issue: 29
关键词: 肺癌,酪氨酸硝化,硝基蛋白质组学,质谱,系统生物学,结构生物学。
摘要: Oxidative/nitrative damage is a crucial element among the complex factors that contribute to lung carcinogenesis. Nitric oxide (NO) free radicals, through chemical modifications such as tyrosine nitration, are significantly involved in lung carcinogenesis and metastasis. NO-mediated protein nitration, which is the addition of the nitro group (–NO2) to position 3 of the phenolic ring of a tyrosine residue, is an important molecular event in lung cancer, and has been studied with mass spectrometry. Nitration is involved in multiple biological processes, including signal transduction, protein degradation, energy metabolism, mitochondrial dysfunction, enzyme inactivation, immunogenic response, apoptosis, and cell death. This article reviews the relationship of NO and its derivates and lung cancer, formation and roles of tyrosine nitration in lung cancer, differences of protein nitration between lung cancer and other inflammatory pulmonary diseases, current status of protein nitration and nitroproteomics in lung cancer, and future perspectives to achieve a better understanding of lung carcinogenesis, for biomarker discovery; and for new diagnostic and prognostic monitoring, and therapeutic targets.
Export Options
About this article
Cite this article as:
Protein Tyrosine Nitration in Lung Cancer: Current Research Status and Future Perspectives, Current Medicinal Chemistry 2018; 25 (29) . https://dx.doi.org/10.2174/0929867325666180221140745
DOI https://dx.doi.org/10.2174/0929867325666180221140745 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery
Current Pharmaceutical Design The Immune System in Cancer Prevention, Development and Therapy
Anti-Cancer Agents in Medicinal Chemistry Lipid Nanoparticles to Deliver miRNA in Cancer
Current Pharmaceutical Biotechnology Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress
Current Drug Metabolism The Role of SAPK/JNK Pathway in the Synergistic Effects of Metformin and Dacarbazine on Apoptosis in Raji and Ramos Lymphoma Cells
Current Molecular Pharmacology Novel Aglycones of Steroidal Glycoalkaloids as Potent Tyrosine Kinase Inhibitors: Role in VEGF and EGF Receptors Targeted Angiogenesis
Letters in Drug Design & Discovery Pro-Oncogenic Cell Signaling Machinery as a Target for Oncolytic Viruses
Current Pharmaceutical Biotechnology Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Targeting the Ataxia Telangiectasia Mutated Protein in Cancer Therapy
Current Drug Targets Pulmonary Arterial Hypertension
Current Vascular Pharmacology A Survey of Prostate Segmentation Techniques in Different Imaging Modalities
Current Medical Imaging Tankyrases: Structure, Function and Therapeutic Implications in Cancer
Current Pharmaceutical Design A Phase I Study of OMN54 (Aneustat™) in Patients with Advanced Malignancies
Clinical Cancer Drugs A Review on Multi-organ Cancer Detection Using Advanced Machine Learning Techniques
Current Medical Imaging Marine Derived Anticancer Drugs Targeting Microtubule
Recent Patents on Anti-Cancer Drug Discovery Metal Containing Chloroquinolines: Beyond Hit and Miss Antimalarial Efficacy to Solid Science
Mini-Reviews in Medicinal Chemistry Improvements in Algorithms for Phenotype Inference: The NAT2 Example
Current Drug Metabolism A Case Study from the Chemistry Core of the Pittsburgh Molecular Library Screening Center: The Polo-like Kinase Polo-Box Domain (Plk1- PBD)
Current Topics in Medicinal Chemistry Oncorine, the World First Oncolytic Virus Medicine and its Update in China
Current Cancer Drug Targets Enzyme Inhibition as a Key Target for the Development of Novel Metal-Based Anti-Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry